日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessment of Adherence to Consolidated Standards of Reporting Trials 2010 Guidelines of Randomized Controlled Trials Published in an Indian and International Pharmacology Journal From 2019 to 2023

对2019年至2023年发表于印度和国际药理学期刊的随机对照试验遵循《临床试验报告规范2010指南》的情况进行评估

Hotwani, Jitendra H; Mahadkar, Pankaj U; Rao, Ankita A

Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial

不同给药方案下超高生物利用度伊曲康唑与常规伊曲康唑治疗无毛癣菌感染的疗效——一项随机临床试验

Shenoy, Manjunath M; De, Abhishek; Shah, Bela; Das, Anupam; Saraswat, Abir; Lahiri, Koushik; Yadav, Sheetal; Sarda, Aarti; Chakraborty, Disha; J, Dharmender; Kamat, Shruti; Doshi, Yashika; Gonsalves, Nelry; Choudhary, Ankita; Dhoot, Dhiraj; Mahadkar, Namrata; Bhushan, Sumit; Gadkari, Rujuta; Barkate, Hanmant

Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea

伊曲康唑超高生物利用度胶囊50毫克与65毫克每日两次治疗无毛癣的疗效比较

Shah, Bela; Mistry, Deval; Jairam, Dharmender; Kansara, Kajal; Pandya, Rutvi; Vasani, Presha; Dhoot, Dhiraj; Mahadkar, Namrata; Bhushan, Sumit; Barkate, Hanmant

Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis

不同剂量下超生物利用度伊曲康唑与常规伊曲康唑在皮肤癣菌病中的药代动力学和临床比较

Dhoot, Dhiraj; Jain, Gaurav Kumar; Manjhi, Mukesh; Kesharwani, Prashant; Mahadkar, Namrata; Barkate, Hanmant

The Optimal Dosing Regimen of Super Bioavailable Itraconazole in Obesity: An Experimental Rat Model Study

超高生物利用度伊曲康唑在肥胖症中的最佳给药方案:一项大鼠实验模型研究

Jain, Gaurav K; Chitnis, Kruttika R; Singhal, Payal; Mahadkar, Namrata; Dhoot, Dhiraj; Barkate, Hanmant

Role of enzymes in growth and morphology of Neurospora crassa: cell-wall-bound enzymes and their possible role in branching

酶在粗糙脉孢菌生长和形态中的作用:细胞壁结合酶及其在分支中的可能作用

Mahadevan, P R; Mahadkar, U R